Sapan K. Behera

Plot No. 201, B/1, Western Express Highway, Goregaon
Mumbai, MH 400063, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Safety and Effectiveness of a Fixed-Dose Combination of Cephalexin Extended Release and Clavulanate Potassium in Bacterial Sore Throat and Uncomplicated Skin and Soft-Tissue Infections: A Multicentre, Open-Label, Phase IV Study in India.

Safety and Effectiveness of a Fixed-Dose Combination of Cephalexin Extended Release and Clavulanate Potassium in Bacterial Sore Throat and Uncomplicated Skin and Soft-Tissue Infections: A Multicentre, Open-Label, Phase IV Study in India.

Journal: Drugs - real world outcomes
Published: December 03, 2025

Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative study.

Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative study.

Journal: Journal of anxiety disorders
Published: September 22, 2025

Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled Study.

Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled Study.

Journal: Journal of diabetes
Published: September 17, 2025

Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR.

Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR.

Journal: Advances in therapy
Published: June 05, 2025

Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study.

Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study.

Journal: Ophthalmology and therapy
Published: December 05, 2023

Effects of Vitamin D on Migraine: A Meta-Analysis.

Effects of Vitamin D on Migraine: A Meta-Analysis.

Journal: Neurology India
Published: August 28, 2023

Indian Council of Medical Research's National Ethical Guidelines for biomedical and health research involving human participants: The way forward from 2006 to 2017.

Indian Council of Medical Research's National Ethical Guidelines for biomedical and health research involving human participants: The way forward from 2006 to 2017.

Journal: Perspectives in clinical research
Published: August 13, 2019

Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson's Disease Patients with Cognitive Deficits: A Meta-Analysis.

Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson's Disease Patients with Cognitive Deficits: A Meta-Analysis.

Journal: Parkinson's disease
Published: May 03, 2019

Are drug-drug interactions a real clinical concern?

Are drug-drug interactions a real clinical concern?

Journal: Perspectives in clinical research
Published: April 23, 2019

A complex interaction between antitubercular treatment and acenocoumarol.

A complex interaction between antitubercular treatment and acenocoumarol.

Journal: European journal of clinical pharmacology
Published: March 21, 2019

A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis.

A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis.

Journal: Current drug safety
Published: November 19, 2018

Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity.

Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity.

Journal: Current clinical pharmacology
Published: October 19, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026